Search - tctmd.com

Displaying 1 - 20 of 197

Sort: Relevancy | Date

Presentation TCT 2025

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

Presenter: Osamu Iida

October 26, 2025

Presentation TCT 2025

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

Presenter: Seung-Whan Lee

October 26, 2025

Presentation TCT 2025

CFA: Is it Still Surgery First?

Presenter: Matthew T. Menard

October 26, 2025

Presentation TCT 2025

Long Segment SFA Disease – Surgery vs. PTAB

Presenter: Ehrin J. Armstrong

October 26, 2025

Presentation TCT 2025

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Presenter: Brian G. DeRubertis

October 26, 2025

Presentation TCT 2025

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Presenter: Dierk Scheinert

October 26, 2025

Presentation TCT 2025

Landscape of Drug Eluting Technology for SFA

Presenter: Aloke Finn

October 26, 2025

Presentation TCT 2024

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

Atherectomy/IVL: What is Optimal Lesion Preparation for the SFA?

Presenter: Ehrin Armstrong

October 28, 2024

Presentation TCT 2024

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Presenter: Lawrence Garcia

October 28, 2024

Presentation TCT 2021

Case Presentation: Long Segment SFA Occlusion

Presenter: Mohammad Ansari

November 06, 2021

Presentation TCT 2021

TCT 680: Managing Aggressive Restenosis and Stent Under-Expansion in a Reconstructed SFA. Role of Intravascular Ultrasound-Guided Intravascular Lithotripsy

Presenter: Mina Kerolos

November 04, 2021

Presentation TCT 2020

TCT 648: Treatment of a SFA Hemorrhage at Antegrade Perfusion Sheath Site and Successful Reperfusion of an Ischemic Leg Secondary to ECMO Sheath Obstruction with Perfusion Sheath Placement in the Distal Anterior Tibial Artery

Presenter: Chris Rosse

October 14, 2020

Presentation TCT 2020

TCT 545: Transcollateral Intra-Arterial Retrograde Ostial SFA CTO Recanalization for CLI

Presenter: Sehrish Memon

October 14, 2020

Presentation TCT 2019

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

Presenter: Thomas Zeller

September 27, 2019

Presentation TCT 2019

Treating Challenging SFA Disease in the Era of Paclitaxel Uncertainty

Presenter: Aravinda Nanjundappa

September 27, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Presenter: Konstantinos Katsanos

September 26, 2019

Advertisement

TCT 461: Long-Term Outcomes of a Sirolimus-Eluting Balloon in Femoropopliteal Lesions: 36-Month Stratified Analysis by Lesion Location from the SELUTION SFA Japan Study

TCT 464: Comparative Effectiveness and Safety of Low-Dose versus High-Dose Paclitaxel Drug-Coated Balloons for Femoropopliteal Artery Disease: One-Year Results from the DCB-SFA Randomized Trial

CFA: Is it Still Surgery First?

Long Segment SFA Disease – Surgery vs. PTAB

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Landscape of Drug Eluting Technology for SFA

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Atherectomy/IVL: What is Optimal Lesion Preparation for the SFA?

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Case Presentation: Long Segment SFA Occlusion

TCT 680: Managing Aggressive Restenosis and Stent Under-Expansion in a Reconstructed SFA. Role of Intravascular Ultrasound-Guided Intravascular Lithotripsy

TCT 648: Treatment of a SFA Hemorrhage at Antegrade Perfusion Sheath Site and Successful Reperfusion of an Ischemic Leg Secondary to ECMO Sheath Obstruction with Perfusion Sheath Placement in the Distal Anterior Tibial Artery

TCT 545: Transcollateral Intra-Arterial Retrograde Ostial SFA CTO Recanalization for CLI

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

Treating Challenging SFA Disease in the Era of Paclitaxel Uncertainty

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

New Insights From Our Meta-Analysis of Paclitaxel-Coated Device Randomized Trials for SFA Disease (And the Response It Has Generated)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content